Pentigetide
Alternative Names: Human IgE pentapeptide; PentydeLatest Information Update: 29 Jul 1993
At a glance
- Originator Dura Pharmaceuticals
- Developer Bausch & Lomb; Carlbiotech; Dura Pharmaceuticals; Tanabe Seiyaku
- Class Antiallergics; Immunoglobulin isotypes; Peptide fragments; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic conjunctivitis; Allergic rhinitis; Asthma
Most Recent Events
- 29 Jul 1993 Discontinued-Clinical for Allergic conjunctivitis in USA (Ophthalmic)
- 29 Jul 1993 Discontinued-Clinical for Allergic rhinitis in USA (Intranasal)
- 29 Jul 1993 Discontinued-I for Allergic rhinitis in Japan (Intranasal)